Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study

BMC Nephrology

Duvuru Geetha²  Philip Seo¹  Rebecca L. Manno¹ 

[1] Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Room 1B.13, Baltimore, 21224, MD, USA;Division of Nephrology, Johns Hopkins Vasculitis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA

关键词: Hemodialysis;    Vasculitis;    Elderly;    ANCA;   

Others  :  1220056
DOI  :  10.1186/s12882-015-0082-9

 received in 2015-01-20, accepted in 2015-06-04,  发布年份 2015

【 摘 要 】

Background

ANCA-associated vasculitis (AAV) with renal involvement is not uncommon in older individuals. Unfortunately, this can be catastrophic requiring hemodialysis (HD) and may lead to end stage renal disease (ESRD). However, more than 50 % of patients with AAV who require HD initially have renal recovery and discontinue HD. The aim of this study was to describe a retrospective cohort of older patients with AAV and severe renal involvement which required hemodialysis.

Methods

Between 1995 and 2013 a total of 30 patients with histologic evidence of pauci-immune glomerulonephritis who required HD were evaluated at a single university center. The association of demographic and clinical parameters with age was assessed. Older age of disease onset was defined as age ≥60 years. The risk of developing ESRD at 3 months was examined using univariate logistic regression analysis.

Results

Among 30 patients with AAV who required HD, the mean age of disease onset was 59 ± 17 years (range 22-88 years). Twelve patients were in the older age group, and 18 were in the younger group. Three months after diagnosis, 43 % of the cohort had ESRD with a statistically similar proportion of older (n = 9, 50 %) versus younger (n = 4, 33 %) patients (p = 0.367). Most patients (93 %) received immunosuppressive therapy. There was not a statistically significant association between age and ESRD.

Conclusions

These data suggest that age alone does not predict renal recovery among individuals on HD due to AAV. Renal recovery is a realistic expectation and outcome, if patients are treated, even among older patients with AAV who require HD initially.

【 授权许可】

   
2015 Manno et al.

【 参考文献 】

• [1]CDC. The State of Aging and Health in America. 2013. http://www.cdc.gov/aging/pdf/state-aging-health-in-america-2013.pdf, accessed on 5/8/15
• [2]Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000; 43(2):414-419.
• [3]Langford CA. Vasculitis in the geriatric population. Clin Geriatr Med. 2005; 21(3):631-647, viii.
• [4]Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013; 12(4):477-482.
• [5]Day CJ, Howie AJ, Nightingale P et al.. Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis. 2010; 55(2):250-258.
• [6]Flossmann O, Berden A, de Groot K et al.. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011; 70(3):488-494.
• [7]de Joode AA, Sanders JS, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013; 8(10):1709-1717.
• [8]Booth AD, Almond MK, Burns A et al.. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003; 41(4):776-784.
• [9]Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s granulomatosis and prospective follow-up. Rheumatology (Oxford). 2001; 40(5):492-498.
• [10]Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century–a disease of older patients. Rheumatology (Oxford). 2005; 44(4):495-501.
• [11]Lee T, Gasim A, Derebail VK et al.. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014; 9(5):905-913.
• [12]De Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al.. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2007; 18(7):2189-2197.
• [13]Berden AE, Ferrario F, Hagen EC et al.. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010; 21(10):1628-1636.
• [14]Tanna A, Guarino L, Tam FW, et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant. 2014; [Epub ahead of print].
• [15]Jennette JC, Falk RJ, Bacon PA et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of the Vasculitides. Arthritis Rheum. 2013; 65(1):1-11.
• [16]Bomback AS, Appel GB, Radhakrishnan J et al.. ANCA-associated glomerulonephritis in the very elderly. Kidney Int. 2011; 79(7):757-764.
• [17]Li ZY, Gou SJ, Chen M, Zhao MH. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum. 2013; 42(5):515-521.
• [18]Szpirt WM. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis – a 25-year perspective. Nephrol Dial Translplant. 2015; 30 Suppl 1:i146-i149.
• [19]Bomback AS, Appel GB. ANCA-associated GN – to PLEX or not to PLEX? Nat Rev Nephrol. 2013; 9:436-438.